COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,684 Articles (22,913 medRxiv, 8,771 bioRxiv)

Most recent first Previous |  Page 842: Articles 8411-8420  | Next

Comparative analysis of the outcomes of COVID-19 between patients infected with SARS-CoV-2 Omicron and Delta variants: a retrospective cohort study
Gunadi, , Hakim, M. S., Wibawa, H., Vujira, K., Puspitarani, D. A., Supriyati, E., Trisnawati, I., Iskandar, K., Khair, R. E., Afiahayati, , Siswanto, , Puspadewi, Y., Irene, , Irianingsih, S. H., Daniwijaya, E. W., Nugrahaningsih, D. A. A., Gabriela, G. C., Geometri, E. T., Eryvinka, L. S., Utami, F. D. T., Devana, E. M., Aditama, L., Kinasih, N. C. P., Amadeus, V. C., Hediningsih, Y., Ananda, N. R., Arguni, E., Nuryastuti, T., Wibawa, T.
10.1101/2022.04.30.22274532 — Posted: 2022-05-03
Describing COVID-19 Patients During The First Two Months of Paxlovid (Nirmatrelvir/Ritonavir) Initiation in a Large HMO in Israel
Tene, L., Chodick, G., Fallach, N., Ansari, W., Distelman-Menachem, T., Maor, Y.
10.1101/2022.05.02.22274586 — Posted: 2022-05-03
Continued Emergence and Evolution of Omicron in South Africa: New BA.4 and BA.5 lineages
Tegally, H., Moir, M., Everatt, J., Giovanetti, M., Scheepers, C., Wilkinson, E., Subramoney, K., Moyo, S., Amoako, D. G., Althaus, C. L., Anyaneji, U. J., Kekana, D., Viana, R., Giandhari, J., Maponga, T. G., Maruapula, D., Choga, W., Mayaphi, S. H., Mbhele, N., Gaseitsiwe, S., Msomi, N., Naidoo, Y., Pillay, S., Sanko, T. a., San, J. E., Scott, L., Singh, L., Magini, N. A., Smith-Lawrence, P., Stevens, W. S., Dor, G., Tshiabuila, D., Wolter, N., Preiser, W., Treurnicht, F. K., Venter, M., Davids, M., Chiloane, G., Mendes, A., McIntyre, C., O'Toole, A., Ruis, C., Peacock, T. P., Roemer, C., Williamson, C., Pybus, O. G., Bhiman, J. N., Glass, A. J., Martin, D. P., Rambaut, A., Gaseitsiwe, S., von Gottberg, A., Baxter, C., Lessells, R. J., de Oliveira, T.
10.1101/2022.05.01.22274406 — Posted: 2022-05-02
Omicron infection induces low-level, narrow-range SARS-CoV-2 neutralizing activity
Turelli, P., Zaballa, M. E., Raclot, C., Fenwick, C., Kaiser, L., Eckerle, I., Pantaleo, G., Guessous, I., Stringhini, S., Trono, D.
10.1101/2022.05.02.22274436 — Posted: 2022-05-02
Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit stress granule formation
Dolliver, S. M., Kleer, M., Bui-Marinos, M. P., Ying, S., Corcoran, J. A., Khaperskyy, D.
10.1101/2022.05.02.490272 — Posted: 2022-05-02
The highly conserved stem-loop II motif is important for the lifecycle of astroviruses but dispensable for SARS-CoV-2
Janowski, A. B., Jiang, H., Fujii, C., Owen, M. C., Bricker, T. L., Darling, T. L., Harastani, H. H., Seehra, K., Tahan, S., Jung, A., Febles, B., Blatter, J. A., Handley, S. A., Parikh, B. A., Lulla, V., Boon, A. C., Wang, D.
10.1101/2022.04.30.486882 — Posted: 2022-05-02
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Cao, Y. R., Yisimayi, A., Jian, F., Song, W., Xiao, T., Wang, L., Du, S., Wang, J., Li, Q., Chen, X., Wang, P., Zhang, Z., Liu, P., An, R., Hao, X., Wang, Y., Wang, J., Feng, R., Sun, H., Zhao, L., Zhang, W., Zhao, D., Zheng, J., Yu, L., Li, C., Zhang, N., Wang, R., Niu, X., Yang, S., Song, X., Zheng, L., Li, Z., Gu, Q., Shao, F., Huang, W., Jin, R., Shen, Z., Wang, Y., Wang, X., Xiao, J., Xie, X. S.
10.1101/2022.04.30.489997 — Posted: 2022-05-02
SARS-CoV-2 Main Protease: a Kinetic Approach
Rebetez, T.
10.1101/2022.05.01.490203 — Posted: 2022-05-02
Keeping it close: The role of a Campus COVID Support Team (CCST) in sustaining a safe and healthy university campus during COVID-19
McDonnell, K. A., Castel, A. D., Vyas, A. B., Nagaraj, N. C., Landry, M.
10.1101/2022.05.01.22274540 — Posted: 2022-05-02
Effectiveness of Covid-19 vaccines against SARS-CoV-2 Omicron variant (B.1.1.529): A systematic review with meta-analysis and meta-regression
Pratama, N. R., Wafa, I. A., Budi, D. S., Sutanto, H., Asmarawati, T. P., Wungu, C. D. K.
10.1101/2022.04.29.22274454 — Posted: 2022-05-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).